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Background: The efﬁcacy of epicardial catheter ablation for ventricular tachycardia has been reported.
However, the safest anatomical method for pericardial puncture has not been determined.
Methods: Thirty patients who underwent 3-dimensional computed tomography (3D-CT) preceding catheter
ablations for atrial ﬁbrillation were enrolled in this study. We used the skin surface 1 cm below the
xiphisternum as the puncture site. For the anterior approach, the attainment site was the pericardium of the
mid portion of right ventricular anterior site, and for the posterior approach it was the pericardium of the
inferior ventricular site. The distance and the angle between the 2 sites were measured using 3D-CT.
Results: For the anterior approach, the distance was 54711 mm and the needle angle was 377111 toward
the left scapula and 347121 towards the back of the body. For the posterior approach, the distance was
56710 mm and the corresponding needle angles were 60791 and 867131. The distance correlated with
BMI for the anterior and posterior approaches (anterior approach: r2¼0.43, Po0.001; posterior approach:
r2¼0.49, Po0.001). Liver existed along the pathway of the posterior approach in 11 (37%) of 30 patients, and
through in 2 (18%) of 11 patients. The liver and lung were not located along the pathway of the anterior
approach in any patients.
Conclusions: Performing subxiphoid pericardiocentesis is anatomically safer via the anterior approach than
via the posterior approach.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Ventricular tachycardia (VT) originating from the epicardium is an
important reason for failure of the endocardial ablation procedure [1].
The percutaneous epicardial approach allows for VT ablation in many
cases to be performed in the electrophysiology laboratory [2]. Catheter
ablation (CA) from the epicardium is often required for VT ablation of
non-ischemic cardiomyopathy due to the presence of epicardial
substrates. In a recent survey of 3 tertiary centers performing VT
ablation from the epicardium, CA had a risk of 5% for acute and 2% for
delayed major complications related to epicardial access [3]. The
risks associated with conventional pericardial access using conven-
tional posterior puncture remain. Recently, a modiﬁed pericardial
approach using anterior puncture has been reported, but the safety
has not been systematically assessed [4].
The primary goal of this study was to examine the adequate needle
angle required for the anterior and posterior pericardial approaches.
The secondary goal was to identify the location of surrounding organs
such as lung and liver through the pathway and assess whether the
anterior approach is safer than the posterior approach.
2. Materials and methods
2.1. Patient population
The present study included consecutive 30 patients who under-
went 3-dimensional computed tomography (3D-CT) preceding
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atrial ﬁbrillation (AF) ablation. Pulmonary vein isolation for parox-
ysmal or persistent symptomatic drug-refractory AF was performed
at our center between April 2011 and June 2011. After written
informed consent was obtained, all patients underwent 3D-CT.
2.2. Scan protocol
Area-detector computed tomography (ADCT) was performed
with a 320-detector slice computed tomography system (Aquilion
One, Toshiba Medical System, Toshiba, Otawara, Japan). Before
enhanced ADCT, a non-enhanced ADCT scan was performed with-
out prospective electrocardiographic (ECG)-triggering to establish
the conditions and settings for enhanced ADCT. Computed tomo-
graphy was started at the top of the lung cavity and stopped at the
diaphragm caudally. The CT acquisition parameters were collima-
tion thickness, 0.5 mm; rotation time, 350 ms; tube voltage, 120 kV;
and tube current, auto mA. Scanning was started 5 s after the peak
time of contrast density at the left atrium in 10 mL of test injection.
Images were collected in the supine position. Scanning was initiated
during a single breath-hold. Acquisition was ECG-gated in patients
with sinus rhythm and ECG-non-gated in patients with atrial
ﬁbrillation, and took less than 1 s. A non-ionic contrast medium
(300 mg/mL, iodine) of 0.7 mL/kg was administered through the
antecubital vein with a power injector at a rate of 0.7 mL/kg/10 s
followed by a 30 mL saline ﬂash injected at the same rate.
2.3. Image reconstruction
Cardiac structure images were reconstructed using the cardiac-
phase search software (Phase Navi, slice thickness, 0.5 mm; and
increment, 0.25 mm); the phase of end-systole was selected. Images
were reconstructed using volume rendering and multiplanar recon-
struction methods and analyzed using an ofﬂine workstation for post-
processing (ZIO STATION, AMIN Corporation, Tokyo, Japan) to check
the main anatomic landmarks by multiplanar reformation.
2.4. Measurement data
We used the skin surface 1 cm below the xiphisternum as the
puncture site. For the anterior attainment site, we used the
pericardium of the mid portion of the right ventricular anterior
site, and for the posterior attainment site, we used the pericar-
dium of the ventricular inferior site. The pathway between the
puncture site and the anterior attainment site was deﬁned as the
anterior approach; the pathway between the puncture site and the
inferior attainment site was deﬁned as the posterior approach
(Fig. 1). We measured the distance and angle between the
puncture and attainment sites using a 3D-CT analyzer (ZIO STA-
TION, AMIN Corporation, Tokyo, Japan) and we investigated any
correlation with body weight, height, body mass index (BMI),
LVEDD, and LVESD. Furthermore, we assessed the anatomical
relationship between the surrounding organs, such as the liver
and lungs, and the access pathway using both the anterior and
posterior approaches. Fig. 2A and B shows a representative case for
measuring these parameters.
Fig. 1. Deﬁnition of the puncture site, anterior attainment site, and posterior
attainment site: Blue arrow indicates the puncture site, red circle indicates the
anterior attainment site, and pink circle indicates the posterior attainment site
(upper panel). Pericardiocentesis with anterior puncture and posterior puncture:
Red arrow indicates the anterior approach and pink arrow indicates the posterior
approach (bottom panel).
Fig. 2. (A) The distance and needle angle in the representative case for the anterior
approach. The distance is deﬁned as the minimum distance between blue arrow
and red circle (B) The distance and needle angle in the representative case for the
posterior approach. The distance is deﬁned as the minimum distance between blue
arrow and purple circle and (C) The assumed pathway (green line) of this case was
considered to penetrate the liver.
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2.5. Statistics
The data were tested with the Kolmogorov–Smirnov test and
are presented as mean7SD for normally distributed variables.
Categorical variables are expressed as number and percentage of
patients. A paired Student's t-test was used to compare the
distance and needle angle between the anterior and posterior
approaches. Using a linear regression model, we evaluated the
relationship between the pathway to the pericardial space and
clinical parameters, including BMI, body weight, height, LVEDD,
and LVESD. A P-value o0.05 was considered statistically signiﬁcant.
All statistical analyses were performed with JMP (SAS Institute
Japan, Tokyo, Japan), release 10.
3. Results
3.1. Patient characteristics
Table 1 shows the patient characteristics. Their mean age was
61710 years, 22 (73%) were men, the mean LVEDD was
48.774.9 mm, the mean LVESD was 33.074.9 mm, and the mean
LVEF was 57.877.9%. The mean body height, weight, and BMI
were 1.6670.1 m, 69.9712.3 kg, and 25.273.7 (weight (kg)/
height (m)2), respectively. No sustained ventricular tachyarrhyth-
mia was documented in any patient.
3.2. Anterior approach
For the anterior approach, Fig. 2A shows the representative
case. In this case, the distance was measured as 52 mm. The needle
angle was 351 towards the left scapula and 351 towards the back of
the body. In all patients, the mean distance was 54.3710.6 mm
between the 2 points. The mean needle angle was 377111
towards the left scapula and 347121 towards the back of the
body (Table 2). The distance correlated with BMI (r2¼0.43,
Po0.001) and body weight (r2¼0.29, P¼0.002) (Fig. 3A), but
not body height (r2¼0.003, P¼0.78), LVEDD (r2¼0.09, P¼0.11),
and LVESD (r2¼0.07, P¼0.16). Additionally, the needle angle
towards the left scapula did not correlate with these parameters
(BMI: r2¼0.11, P¼0.07; body weight: r2¼0.14, P¼0.04; body
height: r2¼0.047, P¼0.25; LVEDD: r2¼0.02, P¼0.41; LVESD:
r2¼0.012, P¼0.57). Moreover, the needle angle toward the back
of the body did not correlate with these parameters (BMI:
r2¼0.04, P¼0.30; body weight: r2¼0.002, P¼0.80; body height:
r2¼0.04, P¼0.30; LVEDD: r2¼0.02, P¼0.44; LVESD: r2¼0.02,
P¼0.41).
3.3. Posterior approach
For the posterior approach, Fig. 2B shows the representative
case. In this case, the distance was measured as 60 mm. The needle
angle was 621 towards the left scapula and 851 towards the back of
the body. In all patients, the mean distance was 55.6710.4 mm.
The distance between anterior and posterior approaches was not
Table 1
Baseline characteristics of the study patients.
Age (year) 61710
Sex male 22/30 Patients
Height (m) 1.6670.1
Weight (kg) 69.9712.3
BMI 25.273.7
LVEDD (mm) 48.774.9
LVESD (mm) 33.074.9
LVEF (%) 57.877.9
BMI, body mass index; LVEDD, left ventricular end diastolic diameter; LVESD, left
ventricular end systolic diameter; and LVEF, left ventricular ejection fraction.
Table 2
The distance, needle angle and surrounding organs for anterior and posterior approaches.
Anterior approach Posterior approach P value
Distance (mm) 54.3710.6 55.6710.4 0.24
Angle (deg)
Toward the left scapula 37711 6079
Toward the back of the body 34712 86713
Surrounding organs
Lung None None
Liver None Along the pathway in 11/30 patients
Through the pathway in 2/11 patients
Fig. 3. Relationship between the distance and angle by each approach and body mass index (BMI). (A) Anterior approach and (B) posterior approach. Of note, in the anterior
and posterior approaches, the distance is correlated with BMI, but not the angle.
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signiﬁcant (P¼0.24). The mean needle angle for the posterior
approach was 60791 towards the left scapula and 867131
towards the back of the body. The distance correlated with
BMI (r2¼0.49, Po0.001) and body weight (r2¼0.26, P¼0.004)
(Fig. 3B), but not body height (r2¼0.005, P¼0.70), LVEDD
(r2¼0.06, P¼0.18), and LVESD (r2¼0.06, P¼0.19). Additionally,
the needle angle towards the left scapula did not correlate with
these parameters (BMI: r2¼0.03, P¼0.35; body weight: r2¼0.05,
P¼0.22; body height: r2¼0.03, P¼0.40; LVEDD: r2¼0.03, P¼0.36;
LVESD: r2¼0.02, P¼0.46). Moreover, the needle angle towards the
back of the body did not correlate with these parameters (BMI:
r2¼0.002, P¼0.80; body weight: r2¼0.01, P¼0.55; body height:
r2¼0.03, P¼0.38; LVEDD: r2¼0.02, P¼0.42; LVESD: r2¼0.03,
P¼0.40).
3.4. Location of surrounding organs
For the anterior approach, the liver and lung were not located
along the pathway. On the other hand, the liver was located along
the pathway in 11 (37%) of 30 patients and through the pathway in
2 (18%) of 11 patients for the posterior approach.
Fig. 2C presents a case of liver injury. The posterior approach
(red line) in this case penetrated the liver, whereas the liver and
lung were not located along the anterior approach (blue line).
4. Discussion
4.1. Main ﬁndings
The techniques of pericardiocentesis including the subxiphoid,
parasternal, and apical approaches are commonly used. Of them,
the subxiphoid approach is the safest without the use of ultra-
sound guidance [5]. Although the subxiphoid approach including
the anterior and posterior approaches has been reported [6],
the anatomical assessment by using 3D-CT has not been well
discussed.
Therefore, with the primary goal of determining the adequate
needle angle, we concluded that anterior puncture with almost
351 toward the left shoulder and caudal direction was recommend-
able as an initial puncture approach. It is helpful to understand the
standard angle of 351 for anterior puncture under ﬂuoroscopic
guidance.
The secondary goal was to identify the existence of surrounding
organs, such as the liver and lungs, through the pathway and
assess whether the anterior approach was safer than the posterior
approach. The liver and lung were not located along or through the
pathway to the pericardial space with the anterior puncture
approach. According to those anatomical considerations, we con-
clude that the anterior approach is recommended as an initial
approach.
4.2. Challenging pericardiocentesis and procedure-related
complications
The pericardial space is usually accessed using an available
needle, originally developed to perform a spinal tap via the
anterior or posterior pericardial approach. Accompanying organ
injuries associated with subxiphoid pericardiocentesis include
cardiac perforation, puncture of coronary arteries, pneumothorax,
arterial bleeding from the diaphragm, and liver injury. Blind
performance is reported as a possible cause of cardiac perforation
and can lead to death [7]. Therefore, elective pericardiocentesis is
currently performed with ultrasound guidance, thus minimizing
cardiac injury by visualizing the relation of the tip of the needle
with the surrounding organs [8].
However, ultrasound guidance can have limited visualization
due to chronic obstructive pulmonary disease, obesity, or an
overall restricted ﬁeld of view. The complication rate has been
reduced using ultrasound guidance; however, difﬁculties with
localizing the needle tip and distinguishing between the myocar-
dium and pericardial space can remain [9].
To the best of our knowledge, assessment about the adequate
needle angle and distance for subxiphoid pericardiocentesis based
on anatomical ﬁndings has not been previously reported, and this
study is the ﬁrst report about the anatomical investigation for
subxiphoid pericardiocentesis.
4.3. Relationship between the adequate pericardiocentesis and
physical size
The posterior approach has conventionally been used for
subcutaneous pericardiocentesis, but the risk of liver injury is
known, even with the usage of ultrasound. Sosa et al. reported that
the needle must always point to the left shoulder, and it must be
introduced more horizontally if the target is the anterior portion of
the ventricles [10]. d'Avila et al. also reported that the needle
should be introduced at a 451 angle towards the left scapula [11].
We demonstrated that the adequate needle angle was almost 351
toward the left shoulder and that the caudal direction was safer
than conventional pericardiocentesis with posterior puncture.
Furthermore, it is not surprising that the distance correlates with
BMI. Of interest, the angle in the anterior puncture does not
correlate with physical size. This indicates that pericardiocentesis
should be more carefully performed in patients with a low BMI in
order not to penetrate the patient's heart. This angle of 351 still
remains an adequate initial approach, regardless of BMI.
4.4. The correlation with surrounding organs
Schmidt et al. reported that 59 patients underwent epicardial
VT ablation following an unsuccessful endocardial VT ablation
procedure [12]. They gained pericardial access as described by
Sosa et al. [2] with liver bleeding due to liver puncture occurring in
2 (3%) patients during the perioperative period. Thus, the conven-
tional pericardiocentesis with posterior puncture described by
Sosa et al. is likely to have a risk of hepatic injury. Recently, Jais
et al. described the use of modiﬁed pericardiocentesis through an
anterior approach [4], and they found that the anterior approach is
safer than the conventional posterior approach. Of note, visceral
complication and pneumothorax related to pericardiocentesis
were not documented in their study. We believe that our anato-
mical evidence supports their conclusions.
4.5. Clinical implications
Recently, the use of the anterior approach has increased
steadily [4,13,14] because of the low rate of complications, and
operability of CA [14]. We demonstrate a safe method for peri-
cardiocentesis. We performed subxiphoid pericardiocentesis
through an anterior approach in 3 cases with VT requiring
epicardial ablation. First, we set the needle almost 1 cm below
the subxiphoid and kept it at 351 toward the left shoulder and
caudal direction. Second, we tried to push and adjust it toward the
anterior pericardial space under biplane ﬂuoroscopy in the ante-
roposterior and left lateral view. In a few cases, we successfully
reached the anterior pericardial space without complication.
Neither the liver nor the lung was located along or through the
anterior approach pathway. We believe that the anterior approach
is safer than the posterior approach. Recently, percutaneous
epicardial ablation has been used successful for the management
of accessory pathways [15], atrial arrhythmias [16], and atrial
J. Teranishi et al. / Journal of Arrhythmia 30 (2014) 491–495494
ﬁbrillation [17]. If a safer pericardiocentesis method is established,
the indication for pericardial ablation would increase. We hope
that this safer subxiphoid pericardiocentesis can be established and
routinely performed in hospital electrophysiology laboratories.
4.6. Study limitations
Our study has 3 major limitations. First, the sample size was
small. Second, this study did not aim to investigate VT in patients
with enlarged left ventricles. Third, the location of the coronary
artery or phrenic artery was not evaluated and coronary angiogra-
phy should be performed before the pericardiocentesis procedure.
5. Conclusion
Based on anatomical ﬁndings, pericardiocentesis is safer and
more reliable via the anterior approach than via the conventional
posterior approach. Therefore, 3D-CT performed before an epicar-
dial CA may reduce procedure-related complications and result in
successful and safe CA.
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